There are several issues involved in getting a new antibiotic drug available to the public. The primary one in these cases is funding for research and development. It is very difficult to get anyone to fund the research and development for new drugs, and part of the reason is that the drugs can only remain proprietary for a short period of time. Soon after development and release, a drug company must release the drug information so that other companies can make generic versions of the drug. This means that it is much more difficult for the drug companies to recover the money spent on research and development. And that is why investors are reticent to invest in the research and development of new drugs.
Click here to cancel reply.
Sorry,At this time user registration is disabled. We will open registration soon!
Don't have an account? Click Here to Signup
© Copyright GreenAnswers.com LLC